Taro U.S.A
Taro Canada
Taro Israel
Taro International
Sun Pharma
Chattem Chemicals Inc.
History
1950
Taro facility for pharmaceutical end products established in Israel
1961
Active pharmaceutical ingredients (API) for Taro products manufactured in Israel
1984
Creams and ointments factory in Canada acquired and operated
1988
Entered US market
2003
Branded product division established
2006
State-of-the-art manufacturing facilities launched at Taro Israel
2010
Taro acquired by Sun Pharmaceuticals
2012
Over $1 billion in gross sales (IMS 2012 sales)
2012
IPO on New York stock exchange.
2016
Taro is leading generic dermatological company in US.
2022
Taro Completes Acquisition of Alchemee.
2024
On June 24, 2024, Taro became a private company and a wholly-owned subsidiary of Sun Pharma and its shares ceased to trade on the NYSE.